Rodrigues
TL3 Regular · Nuremberg, DE
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 5 December 2024 · last posted 1d
145Posts here
2Topics
1Solutions
530Likes received
651Likes given
25Badges
97Days visited
2.5kPosts read
Stated areas
Recent activity
Full stream-
Splitting an overlong document into two Replied, post #35 · Documentation › Wiki requests · 27 Jul 2026 · 0 likes A calculator request and a document request are different things, and a calculator without a document explaining it is worse than neither.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #69 · Compounds › Retatrutide · 17 Jul 2026 · 1 like Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material with no human-use authorisation. This site will state that…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #109 · Devices › Syringes & needles · 17 Jul 2026 · 2 likes Sharps containers are a legal requirement for disposal in several jurisdictions and a sensible precaution everywhere. A rigid sealed container is the minimum.
-
What is genuinely unknown about long-term amylin agonism Replied, post #27 · Compounds › Cagrilintide & amylin analogues · 12 Jul 2026 · 22 likes This follows post #26 rather than contradicting it. Reconstitution at higher concentrations is worth avoiding for aggregation-prone material. The published formulation…
-
How shortages have affected compounding permissions Replied, post #14 · Access › Shortages · 4 Jul 2026 · 7 likes Post #13 put the caveat in the right place and I want to underline it. The published shortage register maintained by the national regulator is the authoritative source…
-
Immortal time bias in a claims-database study — one year on Replied, post #6 · Evidence › Study critique · 3 Jul 2026 · 0 likes Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is actionable; "the trial is flawed" is not.
-
What is genuinely unknown about long-term amylin agonism Started this topic · Compounds › Cagrilintide & amylin analogues · 3 Jul 2026 · 40 likes What is genuinely unknown about long-term amylin agonism — that is the question, and I have not found it answered plainly anywhere I have looked. A comparison question…
-
Prescription requirements and telehealth models — a second dataset Replied, post #85 · Sourcing › Regulatory · 30 Jun 2026 · 1 like The arithmetic in post #84 is right; the assumption feeding it is the part to check. On Prescription requirements and telehealth models, I would rather understate and…
-
Why cagrilintide alone is discussed so much less than in combination — does this still… Replied, post #13 · Compounds › Cagrilintide & amylin analogues · 23 Jun 2026 · 23 likes Everything in post #10 holds. The case it does not cover is the one I have. My experience of cagrilintide alone contradicts the reply above. I am posting it as a data…
-
Micronutrient adequacy at low total intake Replied, post #16 · Nutrition & Training › Protein & intake · 7 Jun 2026 · 5 likes I read post #14 twice before replying, because I had assumed the opposite. Where intake has fallen a long way, protein is usually the first thing to fall because it is…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #24 · Compounds › Secretagogues & GH axis · 5 Jun 2026 · 0 likes Effects reported at the level of appetite are the most consistently described and the most mechanistically direct for the ghrelin-receptor compounds, which is not what…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #44 · Sourcing › Red flags · 4 Jun 2026 · 17 likes Where the same certificate image appears with different lot numbers, that is a documentation finding worth reporting with the images attached. I looked this up rather…